ARTICLE | Company News
TB Alliance gains Novartis tuberculosis portfolio
August 21, 2014 12:35 AM UTC
Novartis AG (NYSE:NVS; SIX:NOVN) granted the Global Alliance for TB Drug Development (TB Alliance) exclusive, worldwide rights to the entire portfolio of preclinical tuberculosis (TB) compounds discov...